Life Sciences And Healthcare Leader Concertai Raises $150 Million Series C From Sixth Street At $1.9 Billion Valuation
Life Sciences And Healthcare Leader Concertai Raises $150 Million Series C From Sixth Street At $1.9 Billion Valuation
03/29/22, 6:30 AM
Location
cambridge
Money raised
$150 million
Round Type
series c
ConcertAI, LLC (ConcertAI), the leader in enterprise AI and real-world data (RWD) solutions for life sciences and healthcare, announced the close of its $150 million Series C investment from Sixth Street, a leading global investment firm, at a $1.9 billion valuation.
Company Info
Location
cambridge, maryland, united states
Additional Info
ConcertAI is the global leader in life sciences and healthcare enterprise AI and RWD SaaS solutions. Our mission is to broadly advance the goals of precision medicine, accelerate delivery of innovative new therapies, generate evidence in support of regulatory and reimbursement decisions, support provider clinical decisions, and improve clinical outcomes for patients. We work in partnership with the leading biomedical innovators, health care providers, and medical societies. For more information, visit us at http://www.concertai.com.